Menu

Presentations

The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.

Implementation and Cost Benefit Analysis of the fully automated Idyllasystem in a large laboratory setting

Yi Ding M.D., Ph.D. - Geisinger

presented at Biocartis Corporate Workshop, AMP 2019

Empowering STAT DNA Testing for Molecular Oncology Applications

Gregory J. Tsongalis, BS, MS, PhD. - Dartmouth Hitchcock Medical Center

presented at Biocartis Corporate Workshop, AMP 2017

Biomarker driven therapy in colorectal cancer-established and evolving evidence

Kanwal Raghav, MD, MBBS. -The University of Texas MD Anderson Cancer Center

presented at Biocartis Corporate Workshop, AMP 2017